Changes in the cellular immune system and circulating inflammatory markers of stroke patients

Chao Jiang1,2, Weixia Kong3, Yuejuan Wang1

  • 1Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

Oncotarget
|September 30, 2016
PubMed

Insights

Ischemic stroke significantly alters the immune system, decreasing key immune cells like B cells and increasing regulatory T cells (Treg). This immune dysregulation, marked by altered inflammatory markers, may explain stroke patients' heightened infection risk.

Area of Science:

  • Immunology
  • Neurology
  • Pathophysiology

Background:

  • Ischemic stroke triggers complex systemic responses.
  • Understanding immune system dynamics post-stroke is crucial for patient outcomes.

Purpose of the Study:

  • To investigate dynamic changes in cellular immunity and inflammatory markers after ischemic stroke.
  • To correlate immune changes with stroke severity, infection, and lesion characteristics.

Main Methods:

  • Blood analysis of lymphocyte subpopulations and serum inflammatory markers in 96 stroke patients and 99 controls.
  • Assessment of immune changes at days 1, 3, and 7 post-stroke.
  • Correlation analysis with NIH Stroke Scale (NIHSS), splenic/lesion volume, and infection status.

Main Results:

  • Stroke patients showed decreased B cells, Th cells, cytotoxic T cells, NK cells, and increased regulatory T (Treg) cells.
  • Elevated serum levels of TNF-α, CRP, IL-4, IL-6, IL-10, IL-17, IL-23, TGF-β, and decreased IFN-γ were observed.
  • Immune changes correlated with splenic/lesion volume, NIHSS, and infection, suggesting systemic immune dysregulation.

Conclusions:

  • Ischemic stroke induces profound systemic immune alterations.
  • These immune changes may underlie the increased susceptibility to infections in stroke patients.
  • Immune profiling offers insights into stroke pathophysiology and complications.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
684
Inflammation01:38

Inflammation

Overview
63.6K
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
17.9K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K